AHA Issues Advisory on Wearable Cardioverter-Defibrillator Tx

Share this content:
AHA Issues Advisory on Wearable Cardioverter-Defibrillator Tx
AHA Issues Advisory on Wearable Cardioverter-Defibrillator Tx

TUESDAY, March 29, 2016 (HealthDay News) -- Recommendations for use of wearable cardioverter-defibrillators (WCDs) are presented in a scientific statement issued by the American Heart Association and published online March 28 in Circulation.

Jonathan P. Piccini, Sr., M.D., from Duke University in Durham, N.C., and colleagues explored the use of a WCD, which is designed for patients at risk of sudden cardiac death (SCD) who are not immediate candidates for implantable cardioverter-defibrillator (ICD) therapy.

The researchers note that indications for WCD therapy suggest their use when there is a clear indication for an implanted/permanent device, which is accompanied by a transient contraindication or interruption in ICD care. Use of a WCD is reasonable as a bridge to a more definitive therapy, or in situations associated with increased risk of death in which ICDs reduce SCD risk but not overall survival. When there is concern about a heightened risk of SCD, which may resolve over time or with treatment, use of WCDs may be reasonable. In situations in which nonarrhythmic risk is expected to significantly exceed arrhythmic risk, WCDs should not be used.

"It is our opinion that the final decision on the use of the WCD should be based on shared decision making, which would include a frank risk-benefit discussion between the clinician and the patient that acknowledges the uncertainty surrounding the efficacy and safety of the WCD," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Dietary changes, other meds, and even surgery can lower cardiovascular risk similarly to statins

Negative Effects Seen With Video Gaming 9 Hours/Week

Negative Effects Seen With Video Gaming 9+ Hours/Week

Benefits seen with one hour a week, but behavioral problems appear to rise at nine hours a week

Improved Adult Lung Function Linked to Childhood Farm Life

Improved Adult Lung Function Linked to Childhood Farm ...

First study to report beneficial effects of growing up on a farm on adult FEV1

is free, fast, and customized just for you!

Already a member?

Sign In Now »